DOI : 10.1055/s-00000034

Klinische Pädiatrie

Issue 06 · Volume 223 · November 2011 DOI: 10.1055/s-002-22419

20th Annual Meeting of the Working Group “Experimental Neuro-Oncology”

Johannes Wesling Klinikum, Minden, 29.–30. April 2011
Wissenschaftliche Leitung: PD Dr. B. Erdlenbruch


A1
Bender, S; Witt, H; Milde, T; Ryzhova, M; Kulozik, AE; Witt, O; Lichter, P; Korshunov, A; Pfister, SM: Molecular outcome prediction in intracranial ependymoma based on WDR16 expression status
A2
Bode, J; Sabag, A; Kietz, S; Neufeld, G; Lakomek, M: Effects of class-3 semaphorins on brain tumour progression
A3
Cin, H; Meyer, C; Herr, R; Janzarik, WG; Lambert, S; Jones, DTW; Jacob, K; Benner, A; Witt, H; Remke, M; Bender, S; Falkenstein, F; Van Anh, TN; Olbrich, H; Deimling, A von; Pekrun, A; Kulozik, AE; Gnekow, A; Scheurlen, W; Witt, O; Omran, H; Jabado, N; Collins, VP; Brummer, T; Marschalek, R; Lichter, P; Korshunov, A; Pfister, SM: FAM131B-BRAF Fusion Gene Resulting From 7q34 Deletion Leads to MAPK Pathway Activation in Pilocytic Astrocytoma
A6
Dohm, CP; Hülper, P; Kermer, P; Strik, H; Weishaupt, JH: Cdk-inhibition as putative new glioblastoma therapy
A7
Jones, DTW; Zapatka, M; Jäger, N; Wang, Q; Stuetz, A; Rausch, T; Benes, V; Blake, J; Korshunov, A; Schmidt, M; Bartholomae, C; Witt, O; Taylor, MD; Kalle, C von; Brors, B; Eils, R; Korbel, J; Lichter, P; Pfister, SM: First Results from the International Cancer Genome Consortium PedBrain Tumor Project on Whole-Genome Deep Sequencing in Medulloblastoma
A8
Koks, C; De Vleeschouwer, S; Ardon, H; Van Gool, SW: Immunotherapy for malignant glioma: current results of the clinical trials
A9
Kool, M; Koster, J; Remke, M; Korshunov, A; Hielscher, T; Witt, H; Northcott, P; Schouten-van Meeteren, A; Clifford, S; Pietsch, T; Buehren, A von; Rutkowski, S; Cho, Y; Versteeg, R; Haberler, C; Ellison, D; Gilbertson, R; Pomeroy, S; Doz, F; Delattre, O; Taylor, M; Pfister, S: Molecular subtypes in medulloblastoma: an International meta-analysis for profiles, genetic aberrations, clinicopathological features AND SURVIVAL
A11
Lacroix, J; Schlund, F; Adolph, K; Leuchs, B; Hielscher, T; Schlehofer, JR; Rommelaere, J; Pfister, SM; Witt, O; Witt, H: Identification of target genes of Parvovirus H-1 (H-1PV) induced cytopathic effects in medulloblastoma
A12
Milde, T; Zucknick, M; Koch, M; Korshunov, A; Witt, H; Remke, M; Jugold, M; Deimling, A von; Kulozik, AE; Benner, A; Pfister, S; Witt, O: The Pediatric Brain Tumor Preclinical Testing Program: evaluation of an individualized molecular treatment approach
A13
Mullins, C; Linnebacher, M; Schneider, B; Stockhammer, F; Classen, CF: Establishment and characterisation of primary GBM cell lines
A14
Unland, R; Schlosser, S; Mühlisch, J; Frühwald, MC: Epigenetic deregulation of the dopamine receptor D4 in pediatric brain tumors
A15
Vandenberk, L; Verschuere, T; Vanhoven, K; KDks, C; De Vleeschouwer, S; Van Gool, SW: Immunotherapy for malignant glioma: preclinical models to improve efficacy of the immune attack
A16
Witt, H; Jones, DTW; Zapatka, M; Cin, H; Ryzhova, M; Remke, M; Kulozik, AE; Witt, O; Lichter, P; Korshunov, A; Pfister, SM: Identification of a CpG Island Methylator Phenotype (PA-CIMP) in a Subgroup of Pilocytic Astrocytoma
A17
Witt, H; Mack, SC; Ryzhova, M; Bender, S; Sill, M; Isserlin, R; Benner, A; Hielscher, T; Milde, T; Remke, M; Jones, DTW; Northcott, PA; Garzia, L; Bertrand, KC; Wittmann, A; Deimling, A von; Kulozik, AE; Witt, O; Bader, GD; Rutka, JT; Lichter, P; Korshunov, A; Taylor, MD; Pfister, SM: Identification of Two Molecular and Clinical Distinct Entities of Posterior Fossa Ependymoma